Achieve Life Sciences
ACHV
ACHV
28 hedge funds and large institutions have $4.9M invested in Achieve Life Sciences in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
30% less capital invested
Capital invested by funds: $7M → $4.9M (-$2.1M)
Holders
28
Holding in Top 10
–
Calls
$107K
Puts
$34K
Top Buyers
| 1 | +$176K | |
| 2 | +$119K | |
| 3 | +$75K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$38.9K |
| 5 |
HF
HRT Financial
New York
|
+$32K |
Top Sellers
| 1 | -$413K | |
| 2 | -$228K | |
| 3 | -$112K | |
| 4 |
Jane Street
New York
|
-$53K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$45K |